believe study of bimagrumab semaglutide Why Is Eli Lilly Betting Big With Weight Loss Drug Bimagrumab? Bimagrumab and semaglutide combo shows

Poor metabolic health can lead to diseases like type 2 diabetes, cardiovascular disease, and certain cancers

Helpful strategies may include: Eating smaller portions Eating slowly and chewing food thoroughly Stopping as soon as comfortable fullness begins Avoiding heavy, greasy, or very rich meals Drinking fluids regularly throughout the day Following the prescribed dose-escalation schedule Contacting your provider before symptoms become severe The right strategy depends on the symptom

Individuals classified as overweight or obese, typically with a body mass index (BMI) of 30 or higher, are the best candidates for semaglutide GLP-1

When initiating OZEMPIC, consider reducing the dose of concomitantly administered insulin secretagogue (such as sulfonylureas) or insulin to reduce the risk of hypoglycemia [see Warnings and Precautions (5.5), Adverse Reactions (6)]

World Health Organization Western Pacific Region (2016) The Asia-Pacific perspective: redefining obesity and its treatment [Internet] Geneva: World Health Organization